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ABSTRACT
Hematopoietic stem cells (HSCs) are rare, ancestral cells
that underlie the development, homeostasis, aging, and
regeneration of the blood. Here we show that the chromatin-associated protein Ikaros is a crucial self-renewal regulator of the long-term (LT) reconstituting subset of HSCs.
Ikaros, and associated family member proteins, are highly
expressed in self-renewing populations of stem cells. Ikaros
point mutant mice initially develop LT-HSCs with the
surface phenotype cKit1Thy1.1(lo)Lin(-/lo)Sca11Flk2CD1501 during fetal ontogeny but are unable to maintain
this pool, rapidly losing it within two days of embryonic
development. A synchronous loss of megakaryocyte/erythro-

cyte progenitors results, along with a fatal, fetal anemia. At
this time, mutation of Ikaros exerts a differentiation defect
upon common lymphoid progenitors that cannot be rescued
with an ectopic Notch signal in vitro, with hematopoietic
cells preferentially committing to the NK lineage. Althoughdispensable for the initial embryonic development of blood,
Ikaros is clearly needed for maintenance of this tissue.
Achieving successful clinical tissue regeneration necessitates
understanding degeneration, and these data provide a striking example by a discrete genetic lesion in the cells underpinning tissue integrity during a pivotal timeframe of
organogenesis. STEM CELLS 2009;27:3082–3092

Disclosure of potential conﬂicts of interest is found at the end of this article.

INTRODUCTION
A vital issue in stem cell biology is to understand the molecular mechanisms that control the self-renewal and differentiation of long-term hematopoietic stem cells (LT-HSCs) [1].
Identifying key molecular pathways has important implications for not only understanding normal organogenesis, tailoring tissue engineering for regenerative medicine, and cellular
reprogramming, but also for cancer as a disease of aberrant
organogenesis mainly through unbridled cell self-renewal [2].
Indeed, many of the regulatory genes found in HSCs largely
also operate in leukemogenesis and, more generally, carcinogenesis [3, 4]. The majority of these genetic studies reporting
adult stem cell function frequently require the generation of
intricate stage- and tissue-speciﬁc conditional null alleles

since traditional germline mutations in the stem/progenitor
cells that underpin tissue development in a mouse can have
highly deleterious effects on the organism [5, 6].
As a means by which to ascribe gene function in adult
stem cells, and in particular the identiﬁcation of critical protein domains, forward genetic phenotype screening of offspring from mice mutagenized with ethylnitrosourea produces
highly subtle genetic alleles through DNA point mutation [7,
8]. Such a methodology provides greater speciﬁcity for
assigning sequence-to-cell function and was recently used to
identify DNA break repair enzymes as limiting for HSCs during aging [9]. Also employing this strategy, mutation of
Ikaros, a transcription factor largely associated with lymphopoiesis [10], was found to cause a more widespread hematopoietic defect [11]. An analysis of differential isoform [12]
and transgenic marker [13] expression in puriﬁed subsets
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described Ikaros’ role in regulating developmental decisions
during early hematopoiesis, while unfractionated mutant bone
marrow (BM) [14] and fetal liver (FL) [11] transplants
showed that HSC activity was impaired. This defect could
have been due to any one of numerous causes including (a) a
lack of HSCs, or a defect in (b) HSC migration, (c) the HSC
niche, (d) HSC proliferation, (e) HSC differentiation for the
preferential choice of some cell fates ahead of others, or (f)
HSC self-renewal. Here, we show that Ikaros is required for
self-renewal of the LT reconstituting pool of HSCs through a
high-resolution analysis of stem and progenitor cells in FL.
Compared to adult BM HSCs, FL LT-HSCs boast numerous
superior features, such as higher in vivo engraftment levels
[15, 16] and broader developmental spectrum [17, 18]. Given
the precise timing of these changes, intrinsically-timed genetic
switches in LT-HSCs are likely to be tightly coordinated during development, with Ikaros an attractive molecule underlying this ontogenic advantage [19]. Here, we utilize the
recently identiﬁed SLAM marker CD150 [20, 21] on LTHSCs with the well established cKitþThy1.1(lo)Lin(/
lo)Sca1þ (KTLS) phenotype [22] to examine the effects of a
site-speciﬁc Ikaros point mutation on the self-renewing pool
of LT-HSCs.

MATERIALS

AND

METHODS

Mice
C57BL/6-Ka, -Thy1.1, and -Plstc strains were maintained at Stanford University’s Research Animal Facility in accordance with
animal ethics guidelines. Mice used were 8-12 weeks old. For
FLs, the morning of vaginal plug observation was E0.5.

Flow Cytometry
Before sorting, stem/progenitor cells from FL/BM were prepared
by lineage depletion with Dynabeads M-450 (Dynal, Oslo, Norway, www.invitrogen.com/site/us/en/home/brands/Dynal.html) or
cKit-enrichment with streptavidin-conjugated magnetic beads
(Miltenyi,
Bergisch
Gladbach,
Germany,
http://www.
miltenyibiotec.com). Unconjugated lineage mAbs were B220
(clone 6B2), CD3 (2C11), CD4 (GK1.5), CD5 (53-7.3/7.8), CD8
(53-6.7), Gr1 (8C5), Mac1 (M1/70), and TER119. Mac1 was only
used in the Lin cocktail for BM [15] and IL7Ra (A7R34)
included for myeloid progenitors. The Lin depleted cells were
labeled with Tricolor- or PE Texas Red-conjugated goat anti-rat
IgG (Caltag, Burlingame, CA, www.invitrogen.com) and stained
with stem/progenitor cell markers: Sca1 (E13-161-7), cKit (2B8),
Thy1.1 (19XE5), Flk2 (A2F10) (eBioscience, San Diego, CA,
http://www. ebioscience.com), CD150 (TC15-12F12.2) (Biolegend,
San Diego, CA, http://www.biolegend.com), IL7Ra, CD34
(RAM34) (BD Pharmingen, San Diego, CA, http://www.bdbiosciences.com), and FccR (CD16/32) (2.4G2) (93) (eBioscience). Immature B cell fractions had the common Lin-B220þIgM-NK1.1 phenotype and CD43þCD19 (Fraction A), CD43þCD19þ (Fraction
B), and CD43CD19þ (Fraction C). Lineage cocktails for sorting
non-stem/progenitor cells were as follows: immature B cell: CD3,
Gr1, Mac1, TER119; pro T-cell: CD3, CD4, CD8, B220, CD19
(1D3) (BD), GL3 (BD), CD11c (HL3) (BD), Gr1, Mac1; and neutrophils: CD3, B220, TER119, Sca1. NK cells were sorted/analyzed
with NK1.1 (PK136) (BD) and CD44 (IM7) (eBioscience), and
immature B cells were sorted with CD43 (S7) (BD) and IgM [11–
26] (eBioscience). Unless otherwise indicated, all mAbs were prepared in I.L.W. Lab. Cells were analyzed/sorted on an LSRII, FACSAria, or highly-modiﬁed FACSVantage cytometer (BD, Mountain
View, CA, http://www.bdbiosciences.com). All cells were at least
double-sorted. Dead cells were discriminated by high forward scatter and propidium iodide staining. Fluorescence-activated cell sort-
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ing (FACS) data was analyzed using FlowJo (Tree Star, Inc., Ashland, OR, http://www.treestar.com).

Cell Culture
OP9 BM stromal cells expressing the Notch ligand Delta-like1
(OP9-DL1) and OP9-control (gifts from Juan Carlos ZúñigaPﬂücker) were maintained in minimum essential medium a-MEM
(InVitrogen, Carlsbad, CA, http://www.invitrogen.com) supplemented with 100 U/ml penicillin, 0.1 mg/ml streptomycin, 50 lg/
ml gentamycin, and 10% heat-inactivated fetal calf serum in a
humidiﬁed 5% CO2 incubator at 37 C. FL cells (E12.5: 10,000/
well; E14.5: 2,000/well) were homogenized in a-MEM and plated
onto freshly plated OP9-DL1 stromal cells on a 24-well plate.
The culture was supplemented with 1 ng/ml Flt3L, 2 ng/ml IL15,
1 ng/ml IL6, and 5 ng/ml IL7.

Gene Expression
Total RNA was isolated using TRIzol (InVitrogen) from equivalent cell numbers, digested with DNase I to remove DNA contamination, and used for reverse transcription (SuperScript II kit,
Invitrogen). All reactions were performed in triplicate in an ABI7000 (Applied Biosystems, Foster City, CA, http://www.appliedbiosystems.com) using SYBR Green (Applied Biosystems) and
cDNA equivalent of 500 cells. Fold expression relative to
whole BM was calculated following b-actin transcript normalization. Primer sequences are included in supplemental online Table
S1.

Statistics
Data were analyzed for signiﬁcance between groups using a twotailed Student’s t-test. Differences were considered signiﬁcant at
p < .05.

RESULTS
Expression of Ikaros Family Members
Throughout Hematopoiesis
The Ikaros protein family has been reported to play a critical
role in blood cell development, including at the level of the
least differentiated cells [11–14]. In particular, the ENUinduced point mutant allele strain Plastic (Plstc) showed that
Ikaros exerts a broader effect on hematolymphoid differentiation, extending well beyond its recognized function in lymphocyte development and homeostasis [7]. Plstc homozygotes
were strikingly anemic and lethal at E15.5 with a complete
failure of FL to engraft hematopoiesis in irradiated recipients
[11].
We ﬁrst sought to garner insight as to how the expression
of Ikaros and its family member genes ﬂuctuate during adult
hematopoiesis starting from LT-HSCs through to mature cells.
In total, 25 cell populations were analyzed by quantitative
real-time polymerase chain reaction (qRT-PCR) and expression levels compared to mean fold change relative to mouse
whole BM (Table 1). The hematopoietic stem and multipotent
progenitor cell subfractions within the KLS population were
sorted with the more well established cell surface markers
Thy1.1 [22] and CD34 [23] in conjunction with Flk2 [24, 25].
Within both puriﬁed LT-HSC populations, Ikaros mRNA
(encoded by the gene Zfpn1a1) was expressed (6- and 4fold change relative to whole BM for (KLS)Thy1.1(lo)-Flk2
and (KLS)CD34-Flk2 cells, respectively). Relative to all
other primitive cell subsets, transcript levels from two other
family members, Helios (Zfpn1a2) [26] (347- and 122-fold
change) and Eos (Zfpn1a4) [27] (2,216- and 2,772-fold
change), were observed in both LT-HSC subsets. Interestingly, both Helios and Eos expression (140- and 19,300-fold
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Table 1. Expression levels of Ikaros family member genes during hematopoiesis as measured by quantitative real-time polymerase chain
reaction (qRT-PCR)
Population

Ikaros

Aiolos

Helios

Eos

Pegasus

ES cells
LT-HSC(KLS Thyl.1(lo)F1k2)
LT-HSC (KLS CD34F1k2)
ST-HSC (KLS CD34þF1k2)
MPP (KLS Thyl.1F1k2þ)
MPP (KLS CD34þF1k2þ)
CLP
CMP
GMP
MEP
B cell, Fraction A
B cell, Fraction B
B cell, Fraction C
B cell, B220þIgMþIgD
B cell, B220þIgMþIgDþ
pro Ti (cKitþCD44þCD25)
pro T2 (cKitþCD44þCD25þ)
pro T3 (CD44-CD25þThyi.iþ)
pro T4 (CD44CD25Thy1.1þ)
CD3(hi)CD4þCD8þdouble positive
CD3(hi)CD8þ single positive
CD3(hi)CD4þ single positive
LincKitGriþMaciþ
cKitTER119þ
NK1.1þ

1.3
6.1
4.1
1.1
1.1
8.6
5.8
3.0
0.9
12.7
12.2
1.3
2.3
3.0
9.2
5.3
8.6
1.9
20.3
8.9
5.9
7.1
0.7
2.9
2.5

0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
2.7
3.6
39
41
0.1
0.0
2.0
25.3
22.1
25.7
10.5
0.0
0.0
5.9

140
347
122
69
55
69
0.1
39
42
104
18.3
3.7
10.1
0.0
0.1
105
157
510
225
268
513
255
0.0
0.2
10.4

19,300
2,216
2,772
350
1.5
3.1
83
0.9
1.4
1.5
0.8
174
3.5
2.6
2.7
0.9
1,280
4,686
292
2.6
6,920
8,067
0.8
9.3
1.5

110
5.6
7.4
4.5
2.5
6.4
3.0
3.2
9.1
9.0
3.9
7.0
2.1
5.2
3.0
5.2
5.4
8.2
5.7
11.9
8.1
9.5
1.5
52.0
1.1

Expression levels in all 25 populations listed above are shown as mean fold change relative to mouse whole BM (expression set to 1.0) for
each gene. qRT-PCRs (with 3-actin housekeeping control) were performed using the cDNA equivalent of 500 puriﬁed cells with triplicate
measurement of at least two independently double- or triple-sorted populations. Stem and progenitor cells were sorted according to the gates
described in Figs. 1A, 2A, and 2C. All cells were sourced from adult mouse BM (8-12 weeks old) with the exception of the two mature
1gM-expressing B-cell subsets (spleen), all seven T-cell subsets (thymus), and natural killer cells (spleen). ES cells were mouse D3 cells.

changes, respectively) were also seen in embryonic stem cells,
another self-renewing stem cell population, but were dramatically lower in the next differentiation subset immediately
downstream of LT-HSCs, which had lost LT self-renewal
ability. Pegasus (Zfpn1a5) [27] showed a similar expression
trend, albeit with less striking oscillations across all populations of cell subsets analyzed. By contrast, Aiolos (Zfpn1a3)
was not turned on in any stem/progenitor cell population analyzed and showed the highest mRNA expression levels in
mature B (40-fold change) and T-cells (10- to 25-fold
change) in agreement with its predominant functions in vivo
[28]. The most uniform pattern of expression of Helios transcripts was in puriﬁed T-cell subsets, consistent with its established role in T lymphopoiesis [26]. In agreement with its key
function in erythropoiesis [11, 29], the highest progenitor
level of Ikaros mRNA expression was in megakaryocyte/
erythrocyte progenitors (MEPs) (13-fold change), with
marked expression also in differentiated erythroid cells (cKitTER119þ; 3-fold change). Helios, Eos, and Pegasus expression was also observed in the erythroid lineage, with Helios
expression levels within the three myeloid progenitor subsets
the highest of all family members analyzed relative to mouse
whole BM. As expected, Ikaros expression was also seen in
common lymphoid progenitors (CLPs) (6-fold change), with
concomitant upregulation of Helios and Aiolos expression in
NK lineage cells. Together, these results clearly show that
Ikaros and its binding partners are expressed at the population
level throughout all stages of hematopoietic development and
particularly in self-renewing stem cells and transit-amplifying
progenitors.

Ikaros Is a Genetic Regulator of
KTLS(CD1501) Cells
Having observed high Ikaros expression in the LT subset of
HSCs that was rapidly extinguished in the daughter shortterm (ST)-HSC population, we next sought to directly analyze
the stem cell phenotype in Plstc mice. We chose to use two
independent positive LT-HSC markers (Thy1.1 and CD150)
and so ﬁrst backcrossed Plstc/þ heterozygotes expressing the
Thy1.2 genotype to C57BL/6-Thy1.1 mice. A preliminary
assessment of HSCs via the KLS compartment at E14.5-15.5
suggested the Plstc mutation caused the stem cell pool to signiﬁcantly expand with Plstc/þ heterozygotes and Plstc/Plstc
homozygotes, boasting a 2- and 4-fold increase in KLS
cells, respectively (Fig. 1A, 1C). This step-wise expansion in
the stem cell-containing pool intimated that the Plstc allele
positively exerted a gene dosage effect on HSCs and potentially acted as a neomorphic allele in these cells. A more
detailed examination revealed a similar stepwise increase in
all frequency subsets within the KLS subfraction, including
KTLS LT-HSCs (Fig. 1D). These results were surprising since
they were completely at odds with the established notion of
loss of Ikaros function exerting a deleterious effect on the
HSC pool [11, 14]. Incorporating CD150 to further dissect the
KTLS compartment of LT-HSCs showed there was a stepwise
and signiﬁcant reduction in a clear KTLS(CD150þ) cellular
population: these cells normally comprised 18% of the KLS
compartment (wild-type) but were 9% in Plstc/þ heterozygotes and 0% in Plstc/Plstc homozygotes (Fig. 1A). As
numbers, the KTLS(CD150þ) subfraction normally comprised
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Figure 1. Plastic homozygotes selectively lack cKitþThy1.1(lo)Lin(-/lo)Sca1þ (KTLS)(CD150þ) long-term (LT)-HSCs, but all other KLS subsets are expanded. (A): Expression of HSC markers cKit, Sca, Thy1.1, Flk2, and CD150 in wild-type þ/þ, Plstc/þ, and Plstc/Plstc embryos.
The percentage of KLS cells within the gates is shown, with the exception of the Live, Lin(/lo) plot (left column), which shows percentage of
total white blood cells (WBCs). A representative E14.5 fetal liver (FL) is shown. (B): Expression of CD150 on FL cells gated only according to
FSC vs SSC. Although this fraction contains HSCs, it is predominantly non-HSCs. Percentage total WBCs is shown. A representative E14.5 FL
is shown. (C): Quantitative analysis (mean 6 s.e.m.) of KLS cells in E14.5-15.5 FL shown as percentage total WBCs and cell number. All data
are from more than eight Plstc/Plstc mutants and their sibling controls from three separate experiments. Statistically signiﬁcant differences (p <
.05) between Plstc/Plstc and þ/þ groups are indicated by an asterisk (*); double asterisk (**) is signiﬁcance between Plstc/Plstc and both þ/þ
and Plstc/þ groups. (D): Quantitative analysis (mean 6 s.e.m.) of cellular subfractions within the KLS compartment in E14.5-15.5 FL shown as
percentage total WBCs and cell number. Populations shown within the KLS subcompartment are: (1) Thy1.1(lo)Flk2-; (2) Thy1.1(lo)Flk2þ; (3)
Thy1.1-Flk2þ; (4) Thy1.1(lo)CD150þ; (5) Thy1.1(lo)CD150-; (6) Thy1.1-CD150-; (7) Flk2-CD150þ; and (8) Flk2þCD150-. Abbreviations:
FSC, forward scatter; HSC, hematopoietic stem cell; SSC, side scatter.

around 3,000-4,000 cells in wild-type FL at E14.5 and 6,0008,000 cells at E15.5, but in Plstc homozygotes, this was signiﬁcantly reduced to a mere 400-500 cells, representing a 15to 20-fold reduction in number (p ¼ .0003 at E14.5) (Fig.
1D). By contrast, the KTLS(CD150-) (p ¼ .001 at E14.5) and
KTLS(Flk2þ) (p ¼ .00003 at E14.5) populations were signiﬁcantly expanded in mutant FLs, although their absolute cell
www.StemCells.com

numbers were comparable. Overall, our quantitative analyses
revealed that most mutant subpopulations of cells within the
KLS fraction were expanded, with Plstc/þ heterozygotes giving intermediate reading. Strikingly, the only subset that was
an exception to this trend of accumulated stem/multipotent
progenitor compartments was those KTLS cells expressing
CD150 (Fig. 1D). Although the CD150 promoter was found
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Figure 2. The Plastic point mutation most signiﬁcantly affects CLP and MEP populations. (A): CLPs were gated as Lin-IL7RaþFlk2þcKit(lo)Sca1(lo) cells. Percentage total white blood cells (WBCs) within gates is shown. A representative E14.5 fetal liver (FL) is shown. (B): Quantitative analysis (mean 6 s.e.m.) of CLPs in E14.5-15.5 FL shown as percentage total WBCs and cell number. Data are from more than eight Plstc/
Plstc mutants and their sibling controls from three separate experiments. Statistically signiﬁcant differences (p < .05) between Plstc/Plstc and þ/
þ groups are indicated by an asterisk (*); double asterisk (**) is signiﬁcance between Plstc/Plstc and both þ/þ and Plstc/þ groups. (C): Three
populations of myeloid progenitors—common myeloid progenitors, granulocyte/macrophage progenitors, and megakaryocyte/erythrocyte progenitors—were gated according to their expression of FccR and CD34 within the Lin(-/lo)cKitþSca1-IL7Ra- subfraction. Percentage total WBCs
within gates is shown. A representative E14.5 FL is shown. (D): Quantitative analysis (mean 6 s.e.m.) of myeloid progenitors in E14.5-15.5 FL
shown as percentage total WBCs and cell number. Abbreviations: CLP, common lymphoid progenitor; CMP, common myeloid progenitor; GMP,
granulocyte/macrophage progenitor; MEP, megakaryocyte/erythrocyte progenitor.

to contain several Ikaros consensus binding sites (data not
shown), expression of CD150 was observed at normal levels
(Fig. 1B) and numbers (data not shown) in other non-stem
cell hematopoietic populations of Plstc cells. This indicated
that, rather than acting as a general regulator of this signaling
lymphocyte activation molecule (SLAM) family member, the
point mutation in Ikaros was highly selective in its effect for
only CD150 cells within the ﬁve-parameter KTLS(Flk2-)

HSC fraction. This was a particularly unanticipated result
since independent qRT-PCR experiments found Ikaros mRNA
was not differentially expressed in puriﬁed KTLS(CD150þ)
and KTLS(CD150-) subsets (data not shown).

Ikaros in Progenitors
A recent study reported Ikaros was not required for the initial
segregation of erythro- and lympho-myeloid progenitors but
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Figure 3. Plastic homozygotes initially
appear phenotypically normal and have
normal numbers of KTLS(CD150þ)
long-term hematopoietic stem cells that
they selectively lose within two developmental days, becoming severely anemic
and leaving accumulated numbers of
KTLS(CD150-) cells. (A): Phenotype of
Plstc/Plstc embryo and wild-type sibling
at E12.5-15.5. (B): Quantitative analysis
(mean 6 s.e.m.) of KTLS(CD150þ) and
KTLS(CD150-) populations in E12.5,
E14.5, and E15.5 FL shown as cell number. E14.5 and E15.5 data are replicated
from Figure 1D. Data are from at least
three Plstc/Plstc mutants and their sibling
controls from at least two separate
experiments. Statistically signiﬁcant differences (p < .05) between Plstc/Plstc
and þ/þ groups are indicated by an asterisk (*); double asterisk (**) is signiﬁcance between Plstc/Plstc and both þ/þ
and Plstc/þ groups. Abbreviations:
KTLS, cKitþThy1.1(lo)Lin(-/lo)Sca1þ.

that it was essential for their subsequent cell fate choice [13].
To further elucidate Ikaros’ role at these checkpoints during
differentiation, we performed an analysis of lymphoid and
myeloid progenitors in Plstc mutants. As anticipated, Flk2þ
CLPs were signiﬁcantly reduced with a barely detectable population at E14.5–15.5 compared to wild-type FLs (p ¼ .01 at
E14.5) (Fig. 2A, 2B). By contrast, the only myeloid progenitors to show comparable levels of cellular attrition were Plstc/
Plstc MEPs (20% of wild-type numbers) (Fig. 2C, 2D).
Like HSC and multipotent progenitor (MPP) subsets, Plstc/þ
mutants again had median cell numbers, further implicating a
gene dosage effect. The common myeloid progenitor (CMP)
fraction was also signiﬁcantly decreased in Plstc homozygotes
(p ¼ .02 at E14.5). This was milder than, but consistent with,
a defect along the megakaryoid/erythroid differentiation pathway (p ¼ .0001 at E14.5) through which the CMP has been
hierarchically modeled to act as a conduit. Unlike other precursors, percentages of granulocyte/macrophage progenitors
(GMPs) were signiﬁcantly increased in Plstc homozygotes (p
¼ .01 at E14.5), consistent with prior analyses of Ikaros
mutants [11, 13]. As with previous erythroid assays in vitro
[11], methylcellulose colony assays also revealed largely normal colony-forming unit (CFU)-granulocyte/macrophage,
CFU-granulocyte, and CFU-macrophage colonies produced
from 100 FACS-puriﬁed wild-type or Plstc/Plstc mutant myeloid progenitors in the presence of stem cell factor, Flt3
ligand (Flt3L), IL3, IL11, and GM-CSF (supplemental online
Figs. 1 and 2). The FccR(hi)CD34 cellular subfraction,
which formed a distinct and abundant cellular population in
the Plstc/Plstc mutants, produced predominantly CFU-GM,
CFU-G, and CFU-M colonies with a total plating efﬁciency
www.StemCells.com

of 25%, consistent with commitment to the myeloid lineage
(supplemental online Fig. 2). Therefore, this novel population
appears to be GMP-like, showing decreased levels of CD34
expression based on its in vitro function. By morphology
(stained cytospins of sorted FccR(hi)CD34 cells), they
appear undifferentiated and are indistinguishable from GMPs
but also from other myeloerythroid progenitors (data not
shown). Since CD34 can be cell cycle regulated and there
seems to be a deregulation of myeloid cells in the mutant
Plastic mice [11], we believe the FccR(hi)CD34 population
consists mainly of GMP-like cells. Together, these experiments indicate an active role for Ikaros in myeloid cell fate
decisions, in particular along the erythroid pathway, and are
consistent with earlier studies and the fatal fetal anemia to
which Plstc homozygotes succumb during late gestation.

Ikaros Is a Bona Fide Self-Renewal Regulator of the
Pool of KTLS(CD1501) LT-HSCs
The primitive wave of hematopoiesis generates differentiating
erythrocytes very early to supply the developing embryonic
circulation before the onset of the deﬁnitive hematopoietic
wave including the LT reconstituting HSCs, which persist to
adulthood [30, 31]. This left open the question of how Plstc
homozygotes could boast a blood cell compartment containing
downstream hematopoietic short-term stem/progenitor cells at
E15.5 if they lacked the KTLS(CD150þ) LT-HSC pool. We
characterized this population, and not the KTLS(CD150-) subfraction, as containing the most robustly-engrafting, LT-reconstituting, self-renewing HSCs in a corresponding study using
wild-type animals [32]. To investigate this question, we
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Figure 4. Composition of OP9-DL1 in vitro cultures for T lineage
cells formed from wild-type and mutant E12.5 and E14.5 fetal livers
(FLs). (A): Quantitative (mean 6 s.e.m.) and kinetic analysis of total
white blood cell (WBC) number of OP9-DL1 cultures from E12.5
FLs. (B,C): Quantitative (mean 6 s.e.m.) and kinetic analysis of the
lineage potential of E12.5 (B) and E14.5 (C) FLs showing the percentage of Thy1.2þ cells (of total WBCs) and CD4þCD8þ doublepositive (of Thy1.2þ cells) after culture on OP9-DL1 stromal cells.
Data are from 15 þ/þ. 28 Plstc/þ and nine Plstc/Plstc E12.5 mutants
and 10 þ/þ. 13 Plstc/þ and three Plstc/Plstc E14.5 mutants from
four separate experiments.

examined Plstc/Plstc embryos at earlier developmental timepoints
and
quantiﬁed
their
KTLS(CD150þ)
and
KTLS(CD150-) subsets. The anemia associated with homozygosity of the Plstc allele only becomes apparent at E14.515.5 when fetuses rapidly appear pale and with a marked deﬁcit of red cells in the FL and vitelline and umbilical circulations (Fig. 3A, supplemental online Fig. 3) [11]; if these
embryos had a defect in primitive hematopoiesis, they would
have died at a much earlier embryonic time. At E14.5–15.5,
the KTLS(CD150þ) subfraction is signiﬁcantly reduced 15to 20-fold in cell number, whereas KTLS(CD150) cells and
all other non-LT self-renewing populations are signiﬁcantly
expanded (Fig. 1D). By contrast, E12.5 Plstc/Plstc FLs were
found to contain normal numbers of both KTLS(CD150þ)
and KTLS(CD150) cells with no marked differences
between mutants and wild-type (Fig. 3B). There was a small
but statistically non-signiﬁcant (p ¼ .28) decrease in the num-
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Figure 5. Composition of OP9 and OP9-DL1 in vitro cultures for B
lineage cells formed from wild-type and mutant E12.5 and E14.5 fetal
livers (FLs). (A): Quantitative (mean 6 s.e.m.) and kinetic analysis
of total white blood cell (WBC) number of OP9 cultures from E12.5
FLs. (B,C): Quantitative (mean 6 s.e.m.) and kinetic analysis of the
lineage potential of E12.5 (B) and E14.5 (C) FLs showing the percentage of B220þ cells (of total WBCs) after culture on either OP9
or OP9-DL1 stromal cells.

ber of Plstc/Plstc KTLS(CD150þ) cells, potentially indicative
of this self-renewing cellular compartment’s impending depletion, but otherwise numbers were normal (3,000-5,000
cells). Given that homozygous Plastic mutants contained a
normal-sized pool of KTLS(CD150þ) LT-HSCs at E12.5,
which disappeared by E14.5-15.5 and left accumulated numbers of all non-LT self-renewing cellular subsets, including
KTLS(CD150) cells, this indicated that Ikaros has a crucial
role in the molecular self-renewal machinery for the pool of
the LT-reconstituting subset of HSCs (supplemental online
Fig. 5). The phenotypic consequences of mutation were a
rapid and fatal fetal anemia as a result of exhausted maintenance of the LT self-renewing HSC, leading to dysregulated
erythroid cell differentiation and proliferation from reduced
progenitors.

An Ectopic Notch Signal Fails to Rescue the Ikaros
Lymphoid Developmental Defect in Primitive Hematopoietic Cells
There is compelling evidence of the interaction between
Ikaros and Notch family members in the self-renewal of

Papathanasiou, Attema, Karsunky et al.

3089

Ikaros Positively Regulates NK Lineage
Commitment from Hematopoietic Progenitors
Our in vitro ﬁndings utilizing OP9-DL1 and OP9 stromal cell
cultures supplemented with numerous cytokines including
IL15 compelled us to ﬁnally examine in vivo whether primitive Plastic hematopoietic cells were preferentially developing
into NK lineage cells instead of deﬁnitive lymphoid cells.
Compared to wild-type littermate controls, Plstc/Plstc FLs
showed a 10-fold expansion in the subset of NK1.1þCD44þ
cells [36] at E14.5 according to both cell frequency (Fig. 6A,
6B) and number (Fig. 6C). Plastic heterozygotes showed an
intermediate, stepwise phenotype, intimating that, as with the
effect of Ikaros on HSCs (Fig. 1), the mutant Plstc allele positively exerted a gene dosage effect on NK cells.

DISCUSSION
Figure 6. Plastic mutants have expanded NK lineage commitment.
(A): Expression of NK1.1 and CD44 in Live, TER119- cells from
E14.5 fetal livers (FLs) showing the percentage of total white blood
cells (WBCs). A representative E14.5 FL is shown. (B,C): Quantitative analysis (mean 6 s.e.m.) of NK1.1þCD44þ cells in E14.5 FL
shown as percentage total WBCs (B) and cell number (C). Data are
from ﬁve Plstc/Plstc mutants and their sibling controls from two separate experiments. Statistically signiﬁcant differences (p < .05)
between Plstc/Plstc and þ/þ groups are indicated by an asterisk (*);
double asterisk (**) is signiﬁcance between Plstc/Plstc and both þ/þ
and Plstc/þ groups.

leukemic T-cells [33]. Our phenotypic analyses of Plastic
showed that Ikaros regulates HSC self-renewal, while independent gain-of-function experiments have implicated Notch
signaling as necessary for HSC maintenance [34]. Since the
most pivotal developmental pathway from undifferentiated hematopoietic cells that requires a persistent Notch receptorligand interaction is T-cell development, we examined
whether Plastic FLs containing HSCs and progenitors could
respond to a Notch signal provided ectopically by the OP9DL1 cell line [35]. Compared to wild-type and Plstc/þ littermates, E12.5 Plstc/Plstc FLs (containing predominantly
HSCs) were severely crippled in their proliferative response
to the Notch ligand DL1 with a ﬁve-fold reduction in total
cell numbers generated after 28 days culture (Fig. 4A). Analysis of the small fraction of viable cells derived from the
E12.5 Plstc/Plstc HSCs revealed that 30% were arrested at
the earliest CD4CD8CD44þCD25 (pro T1) stage of development (data not shown). Consistent with the subsequent
depletion of the self-renewing HSC pool, culturing E14.5
Plstc/Plstc FLs with OP9-DL1 produced <5% Thy1.2þ cells
present 21 days compared to 85--90% derived from wild-type
or heterozygous HSCs/progenitors (Fig. 4C and supplemental
online Fig. 4). Plstc/Plstc FL cells also showed a differentiation block when cultured on OP9 cells normally facilitating
B-cell differentiation, consistent with the previously deﬁned
role for Ikaros in both T- and B-cell lineage differentiation
(Fig. 5A). However, consistent with in vivo ﬁndings in thymii
[11], only E12.5 Plstc/Plstc FLs diverted hematopoietic
development to form B220þ cells at the expense of the
Thy1.2þ cells in vitro in response to an ectopic Notch signal
(Fig. 5B, 5C).
www.StemCells.com

This study began with the question of what Ikaros’ role was
in regulating developmental decisions during early hematopoiesis; we knew that mutant Ikaros HSC activity in vivo was
impaired [11, 14], and that Ikaros null mutants lacked the
cKitþLin(-/lo)Sca1þ (KLS) pool which contained the LTHSC subfraction [14]. Here, we have shown Ikaros is a molecular regulator of the HSC pool and that it clearly distinguishes LT-HSC self-renewal from progenitor proliferation.
Ikaros is most highly expressed in self-renewing fractions of
stem cells, and point mutant mice selectively lack the six-parameter cKitþThy.1.1(lo)Lin(/lo)Sca1þCD150þFlk2 phenotype of LT-HSCs, which they fail to maintain and expand,
while all non-self-renewing fractions of cells accumulate in
number. An ectopic Notch signal could not rescue the Ikaros
developmental defect in primitive hematopoietic cells, including self-renewing LT-HSCs, and these cells preferentially
committed to the NK lineage in lieu of B and T
lymphopoiesis.
A vast majority of HSC analyses focus upon the threecolor KLS population. Our initial cursory observation of an
accumulated KLS fraction in Plastic homozygotes at E14.5–
15.5 was surprising given earlier reports that Ikaros was
essential for maintenance of the LT-HSC pool. This data suggested that a point mutation in Ikaros had in fact caused an
increase in HSCs even although previous experiments
reported the lack of these cells. It is well established that the
KLS fraction represents a heterogeneous cellular population
containing LT- and ST-HSCs as well as MPPs. A depleted/
expanded KLS fraction may thus represent depleted/expanded
progenitors rather than a HSC-speciﬁc effect. In order to analyze LT-HSCs, this necessitates the use of more than three
ﬂow cytometric parameters. Beyond the KLS phenotype, our
experiments with Plastic found the highly-characterized
cKitþThy1.1(lo)Lin(/lo)Sca1þ (KTLS) fraction of cells is
further heterogeneous for LT-HSCs, since these mutants had a
population of KTLS cells at E14.5--15.5 that did not express
CD150. Before utilizing CD150 in conjunction with the Plastic mutant, our observation of a population of cells characteristic as KTLS LT-HSCs was, as with the ﬁnding of an
expanded KLS subfraction, irreconcilable with Ikaros’ status
as a stem cell regulator. The point mutation in Ikaros, along
with wild-type in vivo assays, allowed us to positively identify the bona ﬁde LT-HSC population. Our experiences with
Plastic shows the value of genetic mutants in helping clarify
lineage relationships [32] and underscores the importance of
analyzing the complete stem cell phenotype.
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Large-scale gene expression studies have varied in their
success rate for identifying stem cell regulators. For example,
despite strong indications that JamB/Jam2 is robustly
expressed in multiple stem cell populations, functional studies
of this gene failed to produce any stem cell phenotypes [37].
Differences in input cells and bioinformatics protocols and
the complexity of alternatively spliced transcripts in stem
cells [38] have been highlighted as underpinning these variable ﬁndings. When we analyzed the splice isoform distribution of Ikaros in stem and progenitor cells using earlier cellsorting protocols, the transition from LT-HSC to ST-HSC/
MPP came with the addition of Ikaros isoforms, while the
transition to lymphoid precursors and lymphocytes, as well as
neutrophils, added another isoform (Ik-6) lacking DNA binding sequences [12]. On the basis solely of the transcriptional
repertoire, Ikaros would not have emerged as a candidate
stem cell gene: it was robustly expressed in puriﬁed LT-HSCs
(deﬁned as KLSCD34 Flk2) in one [39] of two [21]
microarray studies by our laboratory. A similar pattern was
observed for the polycomb group member Bmi-1, which has a
signiﬁcant role in HSC self-renewal [40, 41]. Furthermore,
although frequently overlooked, genes expressed at relatively
low levels in stem cells may in fact be the most important
regulators of regeneration by virtue of (a) a stem cell’s
uncommittedness to any particular developmental lineage and
(b) their coordinated connectivity within mammalian protein
networks and extensive combinatorial assembly to produce
phenotypes [7]. Appropriate mutations that selectively alter
key protein domains, particularly in stem cells, are pivotal for
dissecting links between genome sequence and phenomic diversity. This was recently shown for the non-homologous
end-joining DNA Ligase IV enzyme that, through hypomorphic point mutation, was identiﬁed as a sensitive regulator of
HSC stress over time when all previously generated null
mutants were early embryonic lethal [9].
We found that Plstc/Plstc FLs fail to undergo signiﬁcant Tcell differentiation in response to an ectopic Notch signal provided by the OP9-DL1 stromal line in vitro, and in vivo preferentially commit to the NK lineage. These ﬁndings indicate that
Ikaros has potentially two distinct functional roles to play during
T/NK-cell lineage commitment from HSCs and progenitors.
First, the expression of Ikaros in the BM niche confers to the
thymus-seeding progenitor cell an ability to respond to a Notch1
signal that directs the commitment to the T/NK-cell lineage, presumably through promoting the transcription of Notch target
genes [42]. Second, at the double-positive T-cell stage, Ikaros is
required to repress Notch1 signaling and prepare cells for positive and negative selection [43] (Y.S. and G.F.H., unpublished
data, June 26, 2009), and a failure to silence Notch signaling at
this checkpoint can facilitate leukemogenesis.
Plastic harbors a point mutation in Ikaros exon four, and
the full-length DNA-binding isoform Ik-1 is generated and
localizes to its normal cellular niche but fails to bind DNA
[11]. This isoform is normally expressed in a broad range of
puriﬁed populations including LT- and ST-HSC, MPP, CLP,
pro-B- and -T-cells, and neutrophils [12]. However, since LTHSCs speciﬁcally expressed only Ik-1 and -2, both of which
contain exon 4, while more severely-truncated isoforms
appeared in the differentiation subsets downstream of LTHSCs [12], our in vivo ﬁndings corroborate with the Plastic
allele having its greatest corruptive effect at the LT-HSC
level. Ikaros and its family member Aiolos have been shown
to operate along with other regulatory factors in a developmentally stage-speciﬁc manner during discrete stages of Bcell differentiation [44]. In this instance, the abundance of
each factor determined regulatory outcome, with, for example,
Ikaros’ chromatin structure, and therefore its potential to be
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expressed at certain concentrations, posited as key to the activation/silencing of genes under its control. In line with reports
of less compacted chromatin in undifferentiated stem cells
compared with differentiated cells [45], a transcriptionallypermissive environment featuring an interplay of multiple lineage-afﬁliated expression programs in HSCs [46, 47], and
Ikaros’ role as a DNA binding moiety of several chromatin
remodeling complexes and bivalent role as both an endogenous gene repressor/activator, it seems likely that Ikaros operates via a similar mechanism in HSCs to antagonize other
proteins (whether family members or other as yet unidentiﬁed
regulators) and direct commitment to particular daughter progenitors. On the basis of expression trends and the extensive
interaction between Ikaros and its family proteins through heterodimerization, family members such as Helios and Eos
would be attractive candidates. A recent study by Georgopoulos and colleagues has shown that Ikaros operates via such a
mechanism by, on the one hand, promoting lymphoid priming
in HSC and in lymphoid-primed multipotent progenitors
(LMPPs) and, on the other hand, preventing the expression of
stem cell genes in LMPPs [48]. Red-cell formation is notable
in this respect since KTLS(CD150þ) LT-HSCs have a highly
accessible erythroid-speciﬁc Gata1 locus [30]. Gata1 is essential for formation of the b-globin active chromatin hub [49],
and chromosome conformation capture assays have found that
Ikaros plays an essential role in the formation of this complex
[29]. The development of reﬁned chromatin immuno precipitation (ChIP) assays on low cell numbers including miniChIP
[50] means it will be interesting to examine the epigenetic
features of KTLS(CD150þ) LT-HSCs and progenitors as they
stepwise differentiate toward mature erythroid cells from both
wild-type and Plastic mutants. Similarly, more detailed
CD150 promoter studies via ChIP will be valuable to determine whether Ikaros directly regulates the CD150 gene,
speciﬁcally in only LT-HSCs or more generally within
hematopoietic tissues. Given the critical role of Ikaros in HSC
self-renewal that we have shown here and the synchronous
regulation of the erythroid lineage as revealed by anemia in
Plastic homozygotes, it will also be important to examine
whether Ikaros exerts a concomitant bivalent regulatory mechanism within progenitor cells primed to erythro/megakaryopoiesis in addition to lymphopoiesis. As we previously noted
[12], alternate Ikaros isoforms in different hematopoietic subsets might identify and play a role in silencing loci, or possibly act as tags for chromatin opening complexes to identify
regulatory regions, similar to bipotential chromatin marks, or
both [48]. Other mouse mutants with phenotypes resembling
Plastic may also be required to connect Ikaros target genes
within molecular pathways in HSCs and progenitors.

CONCLUSION
The data presented here provide clear evidence of a critical
and dynamic role for Ikaros throughout the hematopoietic hierarchy, most pertinently in the KTLS(CD150þ) LT-HSC
subfraction from which deﬁnitive blood cells begin developing during embryogenesis. Althoughdispensable for the initial
embryonic development of blood, Ikaros is clearly needed for
maintenance of this tissue. Elucidating precisely how this factor mechanistically controls self-renewal and cell fate choice
remains a vital future area of research, in addition to the identiﬁcation of new switches and components controlling the
genetic circuitry of normal and cancer stem cells.
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